Zachary D. Urdang
Papers
2
Total Citations
33
H-Index
2
About
Zachary D. Urdang is a clinician-researcher whose work sits at the intersection of head and neck surgical oncology, patient outcomes, and perioperative risk stratification. His research focuses on optimizing treatment paradigms for oropharyngeal squamous cell carcinoma (OPSCC), particularly by comparing functional and survival outcomes between primary transoral robotic surgery (TORS) and primary chemoradiation therapy. In his most-cited 2023 study, Urdang addressed a critical gap in the literature by analyzing differences in outcomes for early-stage OPSCC patients—work that has already garnered 24 citations and informs shared decision-making in the absence of high-powered randomized trials. He has also advanced the application of the modified frailty index (mFI-5) as a predictive tool for complications and survival in the TORS population, demonstrating that preoperative frailty assessment can meaningfully guide surgical planning. His 2024 study on this topic, with 9 citations, underscores his commitment to evidence-based, patient-centered care. Urdang’s contributions are shaping how surgeons balance oncologic efficacy with functional preservation and risk assessment in head and neck cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2